An elderly female obese advanced cancer patient was admitted with altered sensorium and fever. Lab reports were suggestive of an elevated serum creatinine. Empirical antibiotics were uptitrated and dose modified as per creatinine clearance.
Adequate duration of antibiotics was completed with no appreciable response in the patient’s condition.
The family also noticed the absence of appreciable change in sensorium, reduced oral intake and deterioration in general condition and requested that the antibiotics be stopped.

This post evaluates the legality of treatment limitation in advanced cancer in those who might have entered the terminal stage of decline and addresses the legally tenable options available to the Palliatrist.

Q1 Is the common cause pathway valid?
The common cause pathway comes into consideration when withdrawal of life supporting treatment is being considered and calls for the constitution of a primary medical board, a secondary medical board and a joint committee (replaced by intimation to a judicial magistrate first class) to take collective decisions when treatment withdrawal is being considered. Though treatment witholding and withdrawal are accorded the same standing under Indian Law, cessation of antibiotics in this setting might not always constitute treatment withdrawal.

Q2 Are antibiotics to be considered a component of life prolonging treatment?
Antibiotics may be considered as Life prolonging or life sustaining treatment depending upon duration and response. Stopping a course of antibiotics after indicated duration when it has failed to produce an appreciable benefit does not constitute treatment withdrawal.

Q3 What are the legitimate reasons for discontinuing antibiotics in this setting?
Completion of stipulated duration of treatment
Treatment failure (failure to improve despite necessary duration of administration and underlying disease progression)
Issues with obtaining and maintaining venous access (scenarios where central venous access might be considered too invasive or aggressive given goals of care)
Antibiotics causing harm – possible complications like fever and clostridium difficile associated diarrhoea, fungal infection associated with prolonged duration of treatment)
Entry into the dying phase when there has been disease progression along with signs of impending death.

Q4 What are the ethical doctrines applicable to this scenario?
Non-maleficence, beneficence, proportionality, medical ineffectiveness and best interests in an incapacitated patient.

Q5 How does the law in UK differ from that in India on this?
UK law prioritizes Medical Best Interestsand operates on a capacity-based framework. Decisions made by the treating team pertaining to treatment limitation, though subject to statutory best interests framework and appeal, are not subject to a procedural framework requiring judicial approval.
The Indian law differs on this and has no equivalent of the UK Mental capacity act and is based on a procedural framework limited to a very narrow setting – that of treatment withdrawal in patient with terminal illness or persistent vegetative state. The fact that unanimous board decisions effectively end the process and require only intimation to the judiciary has been proven by the Harish Rana case.

Epilogue – This patient was provided symptom directed treatment with essential medications at the end of life which were titrated to comfort. Anticipatory prescribing was instituted in time. Discussions about the goals of care and plan of management which included discussions about quantum of escalation of ongoing infusion, nutrition and intravenous fluids were routinely carried out the bedside.

Disclaimer

Artificial intelligence tools have been employed for conceptual engagement and language refinement. They do not replace critical scholarship, clinical experience, or editorial judgment. Final responsibility for all interpretations, factual accuracy, originality of synthesis, and the quality of the published material rests entirely with the Founder and Editor.